C Bouffioux

5.3k total citations · 1 hit paper
52 papers, 3.9k citations indexed

About

C Bouffioux is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Urology. According to data from OpenAlex, C Bouffioux has authored 52 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Surgery, 11 papers in Pulmonary and Respiratory Medicine and 9 papers in Urology. Recurrent topics in C Bouffioux's work include Bladder and Urothelial Cancer Treatments (20 papers), Urinary and Genital Oncology Studies (16 papers) and Urological Disorders and Treatments (7 papers). C Bouffioux is often cited by papers focused on Bladder and Urothelial Cancer Treatments (20 papers), Urinary and Genital Oncology Studies (16 papers) and Urological Disorders and Treatments (7 papers). C Bouffioux collaborates with scholars based in Belgium, Netherlands and Italy. C Bouffioux's co-authors include Richard Sylvester, J. Alfred Witjes, Donald W. W. Newling, Karl‐Heinz Kurth, Willem Oosterlinck, Adrian P.M. van der Meijden, Louis Denis, K. H. Kurth, Maurizio Brausi and W. Oosterlinck and has published in prestigious journals such as The Journal of Urology, British Journal of Cancer and European Urology.

In The Last Decade

C Bouffioux

50 papers receiving 3.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Predicting Recurrence and Progression in Individual Patients with Stage Ta T1 Bladder Cancer Using EORTC Risk Tables: A Combined Analysis of 2596 Patients from Seven EORTC Trials

2006 2.1k citations Richard Sylvester, Adrian P.M. van der Meijden et al. European Urology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
C Bouffioux Belgium	17	3.2k	1.2k	611	585	542	52	3.9k
Dirk Zaak Germany	32	2.1k 0.6×	619 0.5×	292 0.5×	1.0k 1.8×	564 1.0×	108	3.1k
John A. Heaney United States	25	551 0.2×	105 0.1×	424 0.7×	615 1.1×	215 0.4×	63	1.7k
James E. Coad United States	22	286 0.1×	92 0.1×	212 0.3×	278 0.5×	353 0.7×	84	1.6k
A. Ouzzane France	25	1.1k 0.3×	283 0.2×	272 0.4×	1.3k 2.2×	77 0.1×	67	2.2k
Τοyoaki Uchida Japan	29	548 0.2×	433 0.4×	339 0.6×	1.3k 2.3×	395 0.7×	144	2.5k
Francesco Ricci Italy	27	738 0.2×	43 0.0×	1.1k 1.9×	867 1.5×	345 0.6×	149	2.4k
K.C. Balaji United States	27	658 0.2×	290 0.2×	481 0.8×	727 1.2×	1.1k 1.9×	85	2.2k
Seung Ho Kim South Korea	25	948 0.3×	25 0.0×	1.3k 2.2×	485 0.8×	136 0.3×	97	2.4k
Michiaki Matsushita Japan	28	1.2k 0.4×	62 0.1×	361 0.6×	505 0.9×	198 0.4×	105	2.4k
Gregers G. Hermann Denmark	21	1.1k 0.3×	384 0.3×	370 0.6×	360 0.6×	448 0.8×	59	2.0k

Countries citing papers authored by C Bouffioux

Since Specialization

Citations

This map shows the geographic impact of C Bouffioux's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C Bouffioux with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C Bouffioux more than expected).

Fields of papers citing papers by C Bouffioux

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C Bouffioux. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C Bouffioux. The network helps show where C Bouffioux may publish in the future.

Co-authorship network of co-authors of C Bouffioux

This figure shows the co-authorship network connecting the top 25 collaborators of C Bouffioux. A scholar is included among the top collaborators of C Bouffioux based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C Bouffioux. C Bouffioux is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sylvester, Richard, Adrian P.M. van der Meijden, Willem Oosterlinck, et al.. (2006). Predicting Recurrence and Progression in Individual Patients with Stage Ta T1 Bladder Cancer Using EORTC Risk Tables: A Combined Analysis of 2596 Patients from Seven EORTC Trials. European Urology. 49(3). 466–477. 2101 indexed citations breakdown →

Waltregny, David, Nicolas Hubert, C Bouffioux, et al.. (2002). Intermittent versus continuous total androgen blockade in the treatment of patients with advanced hormone-naïve prostate cancer. Results of a randomiszed prospective multicenter clinical trial. Open Repository and Bibliography (University of Liège). 6 indexed citations

Leval, Jean de, Nicolas Hubert, Laurence Seidel, et al.. (2002). Intermittent Versus Continuous Total Androgen Blockade in the Treatment of Patients with Advanced Hormone-Naive Prostate Cancer: Results of a Prospective Randomized Multicenter Trial. PubMed. 1(3). 163–171. 108 indexed citations

Brausi, Maurizio, Laurence Collette, Karl‐Heinz Kurth, et al.. (2002). Variability in the Recurrence Rate at First Follow-up Cystoscopy after TUR in Stage Ta T1 Transitional Cell Carcinoma of the Bladder: A Combined Analysis of Seven EORTC Studies. European Urology. 41(5). 523–531. 479 indexed citations

Kurth, K. H., et al.. (2000). Treatment of Superficial Bladder Tumors: Achievements and Needs. European Urology. 37(Suppl. 3). 1–9. 97 indexed citations

Bouffioux, C. (1997). Prostate Cancer:To Screen or Not to Screen?. European Urology. 31(1). 2–4. 2 indexed citations

Pawinski, Adam, Richard Sylvester, K. H. Kurth, et al.. (1996). A Combined Analysis of European Organization for Research and Treatment of Cancer, and Medical Research Council Randomized Clinical Trials for the Prophylactic Treatment of Stage TaT1 Bladder Cancer. The Journal of Urology. 156(6). 1934–1941. 187 indexed citations

Mulder, PHM de, G.O.N. Oosterhof, C Bouffioux, et al.. (1995). EORTC (30885) randomised phase III study with recombinant interferon alpha and recombinant interferon alpha and gamma in patients with advanced renal cell carcinoma. British Journal of Cancer. 71(2). 371–375. 46 indexed citations

Bouffioux, C, K. H. Kurth, A. Bono, et al.. (1995). Intravesical adjuvant chemotherapy for superficial transitional cell bladder carcinoma : results of 2 european organization for research and treatment of cancer randomized trials with Mitomycin C and Doxorubicin comparing early versus delayed instillations and short-term versus long-term treatment. The Journal of Urology. 153(3). 934–941. 98 indexed citations

10.

Kurth, K. H., L. Denis, Fiebo ten Kate, et al.. (1992). Prognostic factors in superficial bladder tumors. Ghent University Academic Bibliography (Ghent University). 40 indexed citations

11.

Pavone‐Macaluso, M., Carlo Pavone, F. Rocco, et al.. (1991). Prostatitis, Prostatosis and Prostalgia, Psychogenic or Organic Disease?. Scandinavian Journal of Urology and Nephrology. 25(sup138). 77–82. 10 indexed citations

12.

Bouffioux, C. (1988). Total Androgen Blockade in Advanced Prostatic Cancer. European Urology. 15(3-4). 187–192. 3 indexed citations

13.

Bollack, C, et al.. (1988). Intravesical Chemoresection with 4'-Epi-Doxorubicin inPatients with Superficial Bladder Tumors. European Urology. 14(3). 207–209. 28 indexed citations

14.

Bouffioux, C, L. Denis, K.H. Kurth, M. De Pauw, & R. Sylvester. (1988). [Which intravesical chemotherapy for what tumor of the bladder?].. PubMed. 94(5-6). 251–60. 2 indexed citations

15.

Bouffioux, C, et al.. (1986). Policy on monitoring and reporting results.. PubMed. 221. 33–48. 1 indexed citations

16.

Bouffioux, C. (1985). Intravesical chemoprophylaxis of superficial transitional cell carcinoma of the bladder. When should the drug be given?. PubMed. 185B. 47–55. 1 indexed citations

17.

Bouffioux, C, et al.. (1984). Alpha-Blockers in the Treatment of Benign Prostatic Hypertrophy:Physiological Basis and Review of the Problem. European Urology. 10(5). 306–310. 7 indexed citations

18.

Schulman, Claude C., L. Denis, W. Oosterlinck, et al.. (1983). Early adjuvant adriamycin in superficial bladder carcinoma. World Journal of Urology. 1(2). 86–88. 13 indexed citations

19.

Bouffioux, C. (1975). [Spontaneous favorable outcome of peri-aneurysmal retroperitoneal fibrosis].. PubMed. 43(1). 47–52. 1 indexed citations

20.

Bouffioux, C, et al.. (1972). [Dissolution of a giant staghorn uric calculus by medical treatment].. PubMed. 40(3). 651–9. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact